ClinicalTrials.gg
CompletedNCT07872124Updated Oct 13, 2026

Point-of-Care Ultrasonography for Pediatric Ankle Fracture Detection

An observational study in Pediatric Ankle Fracture, sponsored by Kanuni Sultan Suleyman Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 5 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Kanuni Sultan Suleyman Training and Research Hospital · Observational

Updated Oct 13, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
74
Ages
5 Years to 17 Years
Sex
All
01

Study summary

This prospective observational study evaluated the diagnostic accuracy of point-of-care ultrasonography (POCUS) for detecting ankle fractures in children presenting to the emergency department with acute isolated ankle trauma. Children aged 5-17 years who met at least one Ottawa Ankle Rule criterion were included.

The primary objective was to determine how accurately bedside POCUS identifies pediatric ankle fractures compared with a predefined reference standard. The study also evaluated whether the presence of open growth plates influenced ultrasound interpretation.

Read the detailed description

This was a prospective, single-center observational diagnostic accuracy study conducted in the emergency department of a tertiary academic referral hospital. Consecutive children presenting with acute isolated ankle trauma were screened for eligibility. Participants were eligible if they were 5-17 years of age and fulfilled at least one Ottawa Ankle Rule criterion.

All POCUS examinations were performed before radiographic imaging using a high-frequency linear transducer. The distal tibia, distal fibula, talus, calcaneus, and navicular were systematically evaluated in longitudinal and transverse planes, with particular attention to the region of maximal tenderness. A POCUS examination was considered positive when cortical discontinuity, step-off, or focal cortical irregularity compatible with fracture was identified and negative when these findings were absent.

POCUS examinations were performed by three emergency medicine residents who had completed a structured musculoskeletal POCUS training program consisting of theoretical and hands-on training followed by supervised ankle ultrasonography examinations. POCUS operators were blinded to radiographic findings at the time of ultrasound interpretation.

All participants underwent clinical assessment and three-view conventional radiography. Fracture status was determined using a prospectively defined composite reference standard. Radiographically confirmed fractures were classified as fracture-positive. Computed tomography was selectively performed in patients with negative or equivocal radiographs when persistent clinical concern warranted further imaging. Orthopedic assessment was incorporated into routine clinical care, and participants were prospectively tracked for 14 days for subsequent emergency department visits, additional imaging, or changes in management.

The diagnostic performance of POCUS was evaluated using sensitivity, specificity, positive predictive value, negative predictive value, positive and negative likelihood ratios, overall diagnostic accuracy, and the area under the receiver operating characteristic curve.

02

Conditions studied

  • Pediatric Ankle Fracture

Keywords

  • Point-of-Care Ultrasonography
  • Pediatric Ankle Trauma
  • Diagnostic Accuracy
  • Physeal Fracture
  • Salter-Harris Fracture
03

In context

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital is the lead sponsor of 224 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consisted of pediatric patients presenting with acute ankle trauma to the emergency department of a tertiary academic referral hospital. Consecutive patients were screened for study eligibility during the study period. The study focused on children for whom ankle radiography was clinically indicated according to the Ottawa Ankle Rules.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 5-17 years
  • Presentation to the emergency department with acute isolated ankle trauma
  • Fulfillment of at least one Ottawa Ankle Rule criterion
  • Written informed consent provided by the participant's legal guardian

Exclusion criteria

Exclusion Criteria:

  • Polytrauma
  • Penetrating ankle injury
  • Clinically obvious deformity requiring immediate reduction
  • Previous surgery to the affected ankle
  • Inability to undergo point-of-care ultrasonography (POCUS)
  • Refusal of informed consent
  • Repeated eligible presentation after a participant had already been enrolled in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
74 participants (actual)
Target follow-up
14 Days
Patient registry
Yes

Groups and cohorts

  • Children With Acute Ankle Trauma

    Children aged 5-17 years presenting to the emergency department with acute isolated ankle trauma and meeting at least one Ottawa Ankle Rule criterion. All participants underwent bedside point-of-care ultrasonography (POCUS) before conventional radiography. Fracture status was determined using a prospectively defined composite reference standard.

    Diagnostic Test: Point-of-Care Ultrasonography (POCUS)

Interventions

  • Diagnostic testPoint-of-Care Ultrasonography (POCUS)

    Bedside point-of-care ultrasonography (POCUS) of the injured ankle was performed before conventional radiography using a high-frequency linear transducer (5-15 MHz). The distal tibia, distal fibula, talus, calcaneus, and navicular were systematically evaluated in longitudinal and transverse planes, with particular attention to the region of maximal tenderness. POCUS was classified as positive when cortical discontinuity, step-off, or focal cortical irregularity compatible with fracture was identified and as negative when these findings were absent.

06

What researchers measure

Primary outcomes

  1. Diagnostic Accuracy of POCUS for Pediatric Ankle Fracture Detection

    Diagnostic performance of point-of-care ultrasonography (POCUS) for detecting ankle fractures was assessed against the prospectively defined composite reference standard. Performance measures included sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio, and overall diagnostic accuracy, with 95% confidence intervals where applicable.

    Time frame: Index emergency department visit, with fracture status verified through 14 days

Secondary outcomes

  1. Anatomical Distribution of False-Positive POCUS Findings

    The anatomical distribution of false-positive POCUS findings was assessed to evaluate whether open physeal anatomy contributed to incorrect fracture-positive ultrasound interpretations. False-positive examinations were defined as POCUS findings suggestive of fracture that were not confirmed as fractures by the composite reference standard. False-positive findings were categorized according to anatomical location, including physeal and non-physeal sites.

    Time frame: Index emergency department visit, with fracture status verified through 14 days

07

Study locations

1 site
  • University of Health Sciences, Istanbul Kanuni Sultan Suleyman Training and Research Hospital
    Istanbul, Küçükçekmece 34303, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the reported results may be made available to qualified researchers upon reasonable request to the corresponding author, subject to applicable ethical and institutional requirements.

Supporting information: Informed consent form

Time frame: Data will be available following publication of the study results and will remain available for a period determined by applicable institutional data-retention policies.

Access criteria: De-identified individual participant data may be provided to qualified researchers who submit a reasonable scientific request to the corresponding author. Requests will be considered based on the proposed research purpose and compliance with applicable ethical, institutional, and data-protection requirements. Data will be shared only when the requested use is compatible with participant consent and institutional policies.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07872124
Responsible party
Utku Murat Kalafat (MD, Kanuni Sultan Suleyman Training and Research Hospital) — Principal investigator
First posted
Oct 13, 2026
Start date
Jul 1, 2024
Primary completion
Jul 1, 2025
Completion
Jul 1, 2025
Last update
Oct 13, 2026

Study contacts

Ömer Kepir
principal investigator · University of Health Sciences, Başakşehir Çam and Sakura City Hospital
Utku Murat Kalafat, md
study director · University of Health Sciences, Istanbul Kanuni Sultan Suleyman Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion